Alnylam, Regeneron collaborate on RNAi therapeutics for diseasesAlnylam's and Regeneron's collaboration will leverage both companies’ scientific and technological expertise to focus on a broad range of diseases. Sanofi expands insulin savings programSanofi will offer its insulin for $99 for up to 10 boxes of pens and/or 10 mL vials per month, beginning in June. Amgen gets FDA nod for Evenity Evenity is a new treatment for osteoporosis in postmenopausal women at high risk of fracture. Sandoz launches generic Remodulin Sandoz will collaborate with RareGen to commercialize its generic Remodulin (treprostinil injection). Novartis completes Alcon spin-off Novartis’ spin-off of the Alcon eye care business will allow the company to focus its attention on medicines. Bartell offers vaccinations, education for international travelers Bartell Drugs' travel clinics, which are now available at 57 of its locations, offers travelers a customized plan for any destination. Fresenius Kabi unveils adenosine injection in prefilled syringes Fresenius Kabi is the first company to offer adenosine in both vials and prefilled syringes. Endo launches authorized Proventil generic Endo’s Par Pharmaceutical is distributing the authorized generic of Merck's Proventil. FDA gives tentative nod for Perrigo’s generic Sernivo spray Betamethasone dipropionate had a market value of about $15 million for the 12 months ending February 2019, according to IQVIA. Armas Pharmaceuticals launches 2 generics Armas Pharmaceuticals is introducing generic Xeloda and Gleevec, which had a market value of roughly $108 million and $655 million, respectively. First Previous 518 519 520 521 522 Next Last
